3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Meet Veristat at the Swiss Biotech Day 2025
Veristat is excited to attend Swiss Biotech Day 2025, taking place May 5 - 6, 2025, at the Congress Center Basel, Switzerland.
We look forward to connecting with industry leaders to discuss the evolving landscape of clinical development, regulatory strategy, and partnership opportunities.
With decades of experience guiding biopharma companies through complex clinical and regulatory challenges, Veristat brings scientific-minded, strategic-level thinking to help sponsors accelerate development timelines and deliver high-quality therapies to patients around the world.
Meet our team and discover how Veristat’s flexible full-service solutions accelerate patient access to life-changing treatments—globally and efficiently.
Veristat Attendee:
Anja Buhrer – VP, Regulatory Affairs
Lorenzo Scalise – Business Development Director
Conference Details:
Date: May 5–6, 2025
Location: Congress Center Basel, Switzerland
Learn more about the conference
Schedule a Meeting:
Connect with Veristat experts to learn how we can support your clinical and regulatory goals. Fill out the form to schedule a time to talk with our team.
3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...